Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotime-Nasdaq's best kept secret? -- Ignore unavailable to you. Want to Upgrade?

To: Keith J who wrote (698)	2/16/1998 12:02:00 AM
From: Bill Wexler	Read Replies (2) \| Respond to of 1432

<<, please do not bother us.>> How am I "bothering" you? Is someone forcing you to read my posts? BTW, one of the little red flags I look for when shorting stocks (besides no sales, no earnings, and little chance of ever obtaining any)....is emotional cheerleading which doesn't tolerate dissenting opinion. As I stated previously, if I'm wrong, you can only benefit since I'll be forced to cover at higher prices. Of course...I have yet to see anything that convinces me this is anything more than another overhyped biotech....and I'll continue shorting on every uptick.

To: Keith J who wrote (698)	2/16/1998 1:57:00 PM
From: Twizlre	Respond to of 1432

Thanks kieth for finding those numbers. One of the things I liked about BTIM when I first was doing my DD was that this company was NOT flying through cash and seemed to be frugal in this phase of exsistance. Also if the company was engaged in hype the must do it well if they can convince Abbot Labs to spend @ 2.3 million ( I don't have those figures in front of me now ) on Hextend milestones as well as commiting to finance the studies for Pentalyte. cheers tim